New York Weill Cornell Cancer Center at Cornell University — New York, New York

New York Weill Cornell Cancer Center at Cornell University is a clinical research site located in New York, New York, United States 10021.

Crixeo Health Trust Score: 89/100 (GOOD). This profile has not yet been claimed by the site owner.

New York Weill Cornell Cancer Center at Cornell University has participated in 85 clinical trials with 7 currently active.

Therapeutic areas: Drug/Agent Toxicity by Tissue/Organ, Pancreatic Cancer, Breast Cancer.

Sponsors: Wellstat Therapeutics, Alliance for Clinical Trials in Oncology, National Cancer Institute (NCI).

Sponsor Feasibility Report

Trust Score: 89/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for New York Weill Cornell Cancer Center at Cornell University?

New York Weill Cornell Cancer Center at Cornell University has a Crixeo Trust Score of 89/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has New York Weill Cornell Cancer Center at Cornell University conducted?

New York Weill Cornell Cancer Center at Cornell University has 85 clinical trials on record, with 7 currently active. Their work covers Drug/Agent Toxicity by Tissue/Organ, Pancreatic Cancer, Breast Cancer.

Is New York Weill Cornell Cancer Center at Cornell University accredited by Crixeo Health?

New York Weill Cornell Cancer Center at Cornell University has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about New York Weill Cornell Cancer Center at Cornell University?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.